Reynaldo Nambayan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reynaldo Nambayan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dylan E. O'SUllivan
University of Calgary 1 Department of Community Health Sciences Calgary, Canada
28 shared publications - Marcus Vaska
Library Services, Acute Care Alberta, Calgary, Canada
28 shared publications - Momtafin Khan
Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Calgary, Canada
28 shared publications - Sanjeev Bista
Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique IPLESP, Nemesis Team, Faculté de Médecine Saint-Antoine, 27 rue Chaligny, 75012 Paris, France
28 shared publications - Darren R. Brenner
University of Calgary 1 Department of Oncology, Cumming School of Medicine Calgary, Canada
27 shared publications - Hannah Harsanyi
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
27 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 12 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 12. Funnel plot of odds ratio for breast cancer screening among cancer survivors compared to the cancer-free general population. The outer dashed lines indicate the triangular region within which 95% of studies are expected to lie in the absence of bias. The solid black line corresponds to the summary effect estimate. Black dots correspond to studies included in this analysis.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 12 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 12. Funnel plot of odds ratio for breast cancer screening among cancer survivors compared to the cancer-free general population. The outer dashed lines indicate the triangular region within which 95% of studies are expected to lie in the absence of bias. The solid black line corresponds to the summary effect estimate. Black dots correspond to studies included in this analysis.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 8. Pooled prevalence of breast cancer screening by method of screening ascertainment. The pooled prevalence estimates of breast cancer screening, calculated using random-effects models, are displayed as diamonds with whiskers indicating 95% confidence intervals (CIs). Estimates were pooled separately based on the method used to assess screening, categorized as either self-reported screening participation or medical record review. The chi-square statistic was used to test for differences in pooled estimates across subgroups (p<0.001).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 8. Pooled prevalence of breast cancer screening by method of screening ascertainment. The pooled prevalence estimates of breast cancer screening, calculated using random-effects models, are displayed as diamonds with whiskers indicating 95% confidence intervals (CIs). Estimates were pooled separately based on the method used to assess screening, categorized as either self-reported screening participation or medical record review. The chi-square statistic was used to test for differences in pooled estimates across subgroups (p<0.001).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 13. Sensitivity analysis for meta-analysis of the odds ratio for breast cancer screening comparing cancer survivors to the cancer-free general population excluding studies recruiting ever-screened and age-ineligible participants. The odds ratio (OR) comparing cancer survivors to the cancer-free general population reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). The overall pooled OR calculated using a random-effects model, is represented by a diamond, with its width corresponding to the 95% CI. Studies which included age-ineligible participants (<40 years old), or which defined screening participation as ever being screened were excluded.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 13. Sensitivity analysis for meta-analysis of the odds ratio for breast cancer screening comparing cancer survivors to the cancer-free general population excluding studies recruiting ever-screened and age-ineligible participants. The odds ratio (OR) comparing cancer survivors to the cancer-free general population reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). The overall pooled OR calculated using a random-effects model, is represented by a diamond, with its width corresponding to the 95% CI. Studies which included age-ineligible participants (<40 years old), or which defined screening participation as ever being screened were excluded.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 16 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 16. Pooled odds ratio of breast cancer screening comparing cancer survivors to the cancer-free general population, stratified by method of screening ascertainment. The odds ratio (OR) reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). Estimates were pooled separately based on the method used to assess screening, categorized as either self-reported screening participation or medical record review. The chi-square statistic was used to test for differences in pooled estimates across subgroups (p=0.064). Pooled ORs, calculated using a random-effects model, are represented by diamonds with their width corresponding to the 95% CI.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 16 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 16. Pooled odds ratio of breast cancer screening comparing cancer survivors to the cancer-free general population, stratified by method of screening ascertainment. The odds ratio (OR) reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). Estimates were pooled separately based on the method used to assess screening, categorized as either self-reported screening participation or medical record review. The chi-square statistic was used to test for differences in pooled estimates across subgroups (p=0.064). Pooled ORs, calculated using a random-effects model, are represented by diamonds with their width corresponding to the 95% CI.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 5. Pooled prevalence of breast cancer screening by study quality. The pooled prevalence estimates of breast cancer screening, calculated using random-effects models, are displayed as diamonds with whiskers indicating 95% confidence intervals (CIs). Estimates were pooled separately based on study quality (low, moderate or high, assessed using revised version of the tool proposed by Hoy et al. (33)). The chi-square statistic was used to test for differences in pooled estimates across subgroups (p=0.509).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 5. Pooled prevalence of breast cancer screening by study quality. The pooled prevalence estimates of breast cancer screening, calculated using random-effects models, are displayed as diamonds with whiskers indicating 95% confidence intervals (CIs). Estimates were pooled separately based on study quality (low, moderate or high, assessed using revised version of the tool proposed by Hoy et al. (33)). The chi-square statistic was used to test for differences in pooled estimates across subgroups (p=0.509).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 20 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 20. Pooled odds ratio of breast cancer screening comparing cancer survivors to the cancer-free general population, stratified by time between cancer diagnosis and assessment. The odds ratio (OR) reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). Estimates were pooled separately based on time from cancer diagnosis to screening assessment, categorized as studies with mean/median time since diagnosis ≥5 years, <5 years, or including cancer survivors irrespective of and not reporting on time since diagnosis (i.e., ever diagnosed). The chi-square statistic was used to test for differences in pooled estimates across subgroups (p=0.902). Pooled ORs, calculated using a random-effects model, are represented by diamonds with their width corresponding to the 95% CI.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 20 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 20. Pooled odds ratio of breast cancer screening comparing cancer survivors to the cancer-free general population, stratified by time between cancer diagnosis and assessment. The odds ratio (OR) reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). Estimates were pooled separately based on time from cancer diagnosis to screening assessment, categorized as studies with mean/median time since diagnosis ≥5 years, <5 years, or including cancer survivors irrespective of and not reporting on time since diagnosis (i.e., ever diagnosed). The chi-square statistic was used to test for differences in pooled estimates across subgroups (p=0.902). Pooled ORs, calculated using a random-effects model, are represented by diamonds with their width corresponding to the 95% CI.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
The objectives of this study were to systematically identify studies that (i) quantified the prevalence of breast cancer screening among female survivors of a prior cancer other than breast cancer and (ii) compared the likelihood of undergoing breast cancer screening between cancer survivors and cancer-free controls. Effect estimates were pooled using random-effects meta-analyses. Stratified analyses were performed across primary cancer sites with three or more studies. Sixty-two studies were included in this review. The prevalence of breast cancer screening among female cancer survivors was 0.67 [95% confidence interval (CI), 0.62–0.71], ranging from 0.49 (lung) to 0.75 (cervical) across primary cancer sites. The prevalence of breast cancer screening was higher among studies that ascertained screening through self-report and studies conducted in North America. The odds of undergoing breast cancer screening were significantly greater among cancer survivors compared with cancer-free controls (odds ratio: 1.24; 95% CI, 1.13–1.36). Although cancer survivors had higher rates of breast cancer screening compared with cancer-free controls, overall rates were below population-based screening targets. Given that cancer survivors are at an elevated risk of subsequent breast cancer, future studies should evaluate predictors of screening nonadherence and explore targeted approaches to improve participation in breast cancer screening among cancer survivors.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
The objectives of this study were to systematically identify studies that (i) quantified the prevalence of breast cancer screening among female survivors of a prior cancer other than breast cancer and (ii) compared the likelihood of undergoing breast cancer screening between cancer survivors and cancer-free controls. Effect estimates were pooled using random-effects meta-analyses. Stratified analyses were performed across primary cancer sites with three or more studies. Sixty-two studies were included in this review. The prevalence of breast cancer screening among female cancer survivors was 0.67 [95% confidence interval (CI), 0.62–0.71], ranging from 0.49 (lung) to 0.75 (cervical) across primary cancer sites. The prevalence of breast cancer screening was higher among studies that ascertained screening through self-report and studies conducted in North America. The odds of undergoing breast cancer screening were significantly greater among cancer survivors compared with cancer-free controls (odds ratio: 1.24; 95% CI, 1.13–1.36). Although cancer survivors had higher rates of breast cancer screening compared with cancer-free controls, overall rates were below population-based screening targets. Given that cancer survivors are at an elevated risk of subsequent breast cancer, future studies should evaluate predictors of screening nonadherence and explore targeted approaches to improve participation in breast cancer screening among cancer survivors.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 2. Pooled prevalence of breast cancer screening by age eligibility and screening definition. The pooled prevalence estimates of breast cancer screening, calculated using random-effects models, are displayed as diamonds with whiskers indicating 95% confidence intervals (CIs). Estimates were pooled separately by study population (screening-eligible age only [≥40 years] vs. inclusion of non-eligible ages) and by screening definition (screened within a specified time period vs. ever screened) and the chi-square statistic used to test for differences in pooled estimates across subgroups (p=0.565).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 2. Pooled prevalence of breast cancer screening by age eligibility and screening definition. The pooled prevalence estimates of breast cancer screening, calculated using random-effects models, are displayed as diamonds with whiskers indicating 95% confidence intervals (CIs). Estimates were pooled separately by study population (screening-eligible age only [≥40 years] vs. inclusion of non-eligible ages) and by screening definition (screened within a specified time period vs. ever screened) and the chi-square statistic used to test for differences in pooled estimates across subgroups (p=0.565).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 15 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 15. Pooled odds ratio of breast cancer screening comparing cancer survivors to the cancer-free general population, stratified by study design. The odds ratio (OR) reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). Estimates were pooled separately by study design (cross-sectional vs. case-control), using the chi-square statistic to test for differences in pooled estimates across subgroups (p=0.200). Pooled ORs, calculated using a random-effects model, are represented by diamonds with their width corresponding to the 95% CI.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 15 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 15. Pooled odds ratio of breast cancer screening comparing cancer survivors to the cancer-free general population, stratified by study design. The odds ratio (OR) reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). Estimates were pooled separately by study design (cross-sectional vs. case-control), using the chi-square statistic to test for differences in pooled estimates across subgroups (p=0.200). Pooled ORs, calculated using a random-effects model, are represented by diamonds with their width corresponding to the 95% CI.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 14 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 14. Sensitivity analysis for meta-analysis of the odds ratio for breast cancer screening excluding studies examining breast cancer screening other than screening mammography. The odds ratio (OR) comparing cancer survivors to the cancer-free general population reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). The overall pooled OR, calculated using a random-effects model, is represented by a diamond, with its width corresponding to the 95% CI. Studies which assessed screening methods other than mammography were excluded.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 14 from Breast Cancer Screening among Cancer Survivors: A Systematic Review and Meta-analysis
Supplementary Figure 14. Sensitivity analysis for meta-analysis of the odds ratio for breast cancer screening excluding studies examining breast cancer screening other than screening mammography. The odds ratio (OR) comparing cancer survivors to the cancer-free general population reported in each study is presented numerically and graphically, with point estimates shown as boxes scaled by study weight and whiskers representing the 95% confidence intervals (CIs). The overall pooled OR, calculated using a random-effects model, is represented by a diamond, with its width corresponding to the 95% CI. Studies which assessed screening methods other than mammography were excluded.